254 related articles for article (PubMed ID: 6751080)
1. Hemodynamic and endocrine changes associated with captopril in diuretic-resistant hypertensive patients.
Fujita T; Ando K; Noda H; Sato Y; Yamashita N; Yamashita K
Am J Med; 1982 Sep; 73(3):341-7. PubMed ID: 6751080
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of captopril on cardiopulmonary hemodynamics and renin-angiotensin-aldosterone and bradykinin profile in hypertension.
Mookherjee S; Anderson GH; Eich R; Hill N; Smulyan H; Streeten DH; Vardan S; Warner R
Am Heart J; 1983 Jan; 105(1):106-12. PubMed ID: 6336874
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and neurohumoral factors in the response of hypertensives to hydrochlorothiazide therapy.
Fernandez PG; Snedden W; Nath C; Vasdev S; Lee C; Darke A
Clin Invest Med; 1987 Nov; 10(6):513-9. PubMed ID: 3326694
[TBL] [Abstract][Full Text] [Related]
5. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
[TBL] [Abstract][Full Text] [Related]
7. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
Hashimoto H; Hiwada K; Kokubu T
Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543
[TBL] [Abstract][Full Text] [Related]
8. The effect of captopril on renal hemodynamics in hypertensive patients.
Duchin KL; Willard DA
J Clin Pharmacol; 1984; 24(8-9):351-9. PubMed ID: 6384279
[TBL] [Abstract][Full Text] [Related]
9. The role of renal hemodynamics in the antihypertensive effect of captopril.
Ando K; Fujita T; Ito Y; Noda H; Yamashita K
Am Heart J; 1986 Feb; 111(2):347-52. PubMed ID: 3511649
[TBL] [Abstract][Full Text] [Related]
10. Single administration of captopril and combined use with beta-blocker and/or thiazide diuretic in the treatment of essential hypertension.
Yoneda S; Kako T; Koketsu M; Hayano J; Asakawa T; Fujinami T; Kato T
Angiology; 1991 Nov; 42(11):914-23. PubMed ID: 1683186
[TBL] [Abstract][Full Text] [Related]
11. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
Weber MA; Drayer JI; Priest RT; Chen TC
Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
[TBL] [Abstract][Full Text] [Related]
12. Clinical effects of low-dose captopril plus a thiazide diuretic on mild to moderate essential hypertension: a multicenter double-blind comparison with propranolol. Captopril Research Group of Japan.
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S77-81. PubMed ID: 2580181
[TBL] [Abstract][Full Text] [Related]
13. Moderate sodium restriction, angiotensin converting enzyme inhibition, and thiazide diuretic in the management of essential hypertension.
Singer DR; Markandu ND; Furnival L; Khoshnodi L; MacGregor GA
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S5-7. PubMed ID: 2474103
[TBL] [Abstract][Full Text] [Related]
14. Combined effect of captopril and thiazide diuretic on serum lipid profile in hypertensive women.
Karim S; Karim S; Begum A; Javed N
J Ayub Med Coll Abbottabad; 2001; 13(1):19-21. PubMed ID: 11706633
[TBL] [Abstract][Full Text] [Related]
15. Long-term captopril therapy: evolving hemodynamic effects.
Sullivan JM; Taylor JC; Patrick DR; Johnson JG; Ratts TE; Muirhead EE
J Clin Pharmacol; 1982 Oct; 22(10):450-8. PubMed ID: 6757280
[TBL] [Abstract][Full Text] [Related]
16. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension.
Sassano P; Pedrinelli R; Magagna A; Abdel-Haq B; Salvetti A
Am J Cardiol; 1982 Apr; 49(6):1574-6. PubMed ID: 6280486
[TBL] [Abstract][Full Text] [Related]
17. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
Mizuno K; Shigetomi S; Haruyama K; Matsui J; Gotho M; Fukuchi S
Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526
[No Abstract] [Full Text] [Related]
18. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
[TBL] [Abstract][Full Text] [Related]
19. Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.
Creager MA; Halperin JL; Bernard DB; Faxon DP; Melidossian CD; Gavras H; Ryan TJ
Circulation; 1981 Sep; 64(3):483-9. PubMed ID: 6266691
[TBL] [Abstract][Full Text] [Related]
20. Twice-daily low-dose captopril in diuretic-treated hypertensives.
Murdoch DL; Gillen GJ; Morton JJ; Leckie B; Murray GD; Davies DL; McInnes GT
J Hum Hypertens; 1989 Feb; 3(1):29-33. PubMed ID: 2657056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
